Gapping up
In reaction to earnings/guidance:
- LRN +4.9%, EW +4.5%, ERIC +4.4%, ISRG +3.9%, ASML +3.8%, HWC +3.6%, THC +3%, IBKR +2.4%, TEL +2.1%, RCI +2%, LAD +1.9%, FHN +1.8%, SBNY +1.6%, NEP +1.1%, HAL +1%, NDAQ +1%
M&A news:
- WBT +17.1% (to be acquired by The Middleby Corp (MIDD) in an all-stock transaction)
- FTFT +1.2% (signed a preliminary term sheet to acquire 100% of the equity of Khyber Money Exchange from its shareholder for ~$820k)
Other news:
- ZLAB +4.1% (prices offering of ADS and ordinary shares for gross proceeds of $750 mln)
- TRVN +2.9% (selected for inclusion in an international, multi-site, adaptive, Phase 2-Phase 3 trial in COVID-19 patients)
- KIN +2.8% (unveils "positive" results in an interleukin IL-31 antibody program)
- CP +1.6% (CP comments on CNI unsolicited offer to acquire KSU)
- WES +0.8% (slightly increases quarterly cash distribution)
Analyst comments:
- NCLH +1.9% (upgraded to Buy from Neutral at Goldman)
- CTXS +1.8% (upgraded to Buy from Hold at Jefferies)
- FSS +1.1% (upgraded to Strong Buy from Mkt Perform at Raymond James)
- MS +0.7% (upgraded to Buy from Hold at Berenberg)